Seminars in Radiation Oncology
Volume 19, Issue 3 , Pages 187-192 , July 2009

Normal Tissue Tolerance for High-Grade Gliomas: Is It an Issue?

  • David E. Morris, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr David E. Morris, Department of Radiation Oncology, UNC/Lineberger Comprehensive Cancer Center, 4030 Bondurant Hall, CB #7000, Chapel Hill, NC 27599
    • ,
  • Randall J. Kimple, MD, PhD

References 

  1. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980;303:1323–1329
  2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
  3. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol. 2004;22:1583–1588
  4. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527–1535
  5. Phillips C, Guiney M, Smith J, et al. A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol. 2003;68:23–26
  6. Mirimanoff R, Mason W, van den Bent M, et al. Is Long-term survival in glioblastoma possible? (Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus RT alone). Int J Radiat Oncol Biol Phys. 2007;69:S2
  7. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1999;21:109–122
  8. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002;20:2267–2276
  9. Hahn CA, Dunn RH, Logue PE, et al. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 2003;55:992–999
  10. Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31:1093–1112
  11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  12. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–181
  13. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31:1049–1091
  14. Corn BW, Yousem DM, Scott CB, et al. White matter changes are correlated significantly with radiation dose (Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02)). Cancer. 1994;74:2828–2835
  15. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351–356
  16. Tanaka M, Ino Y, Nakagawa K, et al. High-dose conformal radiotherapy for supratentorial malignant glioma: A historical comparison. Lancet Oncol. 2005;6:953–960
  17. Nagesh V, Tsien CI, Chenevert TL, et al. Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: A diffusion tensor imaging study. Int J Radiat Oncol Biol Phys. 2008;70:1002–1010
  18. Matulewicz L, Sokol M, Michnik A, et al. Long-term normal-appearing brain tissue monitoring after irradiation using proton magnetic resonance spectroscopy in vivo: Statistical analysis of a large group of patients. Int J Radiat Oncol Biol Phys. 2006;66:825–832
  19. Hahn CA, Zhou SM, Raynor R, et al. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and Neurocognitive dysfunction. Int J Radiat Oncol Biol Phys. 2009;73:1082–1087
  20. Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol. 2002;20:1635–1642
  21. Tsien C, Moughan J, Michalski JM, et al. phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group trial 98-03. Int J Radiat Oncol Biol Phys. 2009;73:699–708
  22. Nieder C, Nestle U, et al. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme. Radiat Oncol Invest. 1999;7:36–41
  23. Sultanem K, Patrocinio H, Lambert C, et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys. 2004;58:247–252
  24. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291–298
  25. Souhami L, Seiferheld W, Brachman D, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys. 2004;60:853–860
  26. Storm AJ, van der Kogel AJ, Nooter K. Effect of X-irradiation on the pharmacokinetics of methotrexate in rats: Alteration of the blood–brain barrier. Eur J Cancer Clin Oncol. 1985;21:759–764
  27. Stammler G, Pommerenke EW, Mattern J, et al. Effects of single doses of irradiation on the expression of resistance-related proteins in murine NIH 3T3 and human lung carcinoma cells. Carcinogenesis. 1995;16:2051–2055
  28. Nieto Y, Cagnoni PJ, Bearman SI, et al. Acute encephalopathy: A new toxicity associated with high-dose paclitaxel. Clin Cancer Res. 1999;5:501–506
  29. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:765–773
  30. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation optic neuropathy after megavoltage external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30:755–763
  31. Parsons JT, Bova FJ, Fitzgerald CR, et al. Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys. 1994;30:775–780
  32. Paulino AC, Narayana A, Mohideen MN, et al. Posterior fossa boost in medulloblastoma: An analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46:281–286
  33. Arcicasa M, Roncadin M, Bidoli E, et al. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys. 1999;43:789–793

 RJK has been designated a B. Leonard Holman Pathway Fellow by the American Board of Radiology and is supported by a 2007-08 Phillips Medical Systems/Radiological Society of North America Research Resident Grant and by a 2008 Resident/Fellows in Radiation Oncology Seed Grant from the American Society for Therapeutic Radiology and Oncology.

PII: S1053-4296(09)00024-1

doi: 10.1016/j.semradonc.2009.02.007

Seminars in Radiation Oncology
Volume 19, Issue 3 , Pages 187-192 , July 2009

Article Tools